Association of menopausal hormone therapy with risk of cardiovascular disease in Korean women
There was an increased risk of CVD in MHT users. By regimen, tibolone use was associated with increased risk of CVD, whereas estrogen either alone or in combination with progestogen was not. There was no difference according to the type of estrogen. The type of progestogen seems to modify the results, since dydrogesterone was associated with reduced CVD risk.
Authors
- Dong‐Gil Kim (ORCID: https://orcid.org/0000-0002-7628-1043)
- Gwang Sil Kim
- Young Sup Byun (ORCID: https://orcid.org/0000-0002-6360-6400)
- Sang‐Hee Yoon (ORCID: https://orcid.org/0000-0002-6897-7657)
- Myoung‐Hwan Kim (ORCID: https://orcid.org/0000-0002-7629-6114)
- Gwan Hee Han (ORCID: https://orcid.org/0000-0001-5263-4855)
- Jin‐Sung Yuk (ORCID: https://orcid.org/0000-0002-5478-634X)
- Byung Gyu Kim (ORCID: https://orcid.org/0000-0001-5780-9642)
Institutions
- Inje University Sanggye Paik Hospital (KR)
Publication Details
- Journal
- European Journal of Endocrinology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1093/ejendo/lvae161
- Citations
- 8
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 10.36
Funders
- Ministry of Education
- National Research Foundation of Korea